Formulation development and evaluation of controlled release matrix tablets of glibenclamide

Author:

PALATTY Biji1,RAJ Praveen1,PA Daiay2,JOHNS .G Boby2

Affiliation:

1. St. Joseph's college of Pharmacy

2. St. Joseph's college of Pharmacy, Cherthala

Abstract

The present study aimed to formulate and evaluate the controlled-release matrix tablets of Glibenclamide which is an antidiabetic drug that belongs to the second-generation oral hypoglycemics. Matrix tablets were prepared by three different polymers as sustained-release agents, using Glibenclamide as a model drug. Three polymers were selected for this study- HPMC K 15, HPMC K 100, and EC in different drug: polymer ratios. The drug was identified by FTIR spectroscopic method. The pre-compression and post-compression parameters of all formulations were found to be within acceptable limits. The release rate of Glibenclamide from matrix tablets was studied using the USP Dissolution Testing Apparatus type-I (Basket method). The formulation F6 which contained EC 50mg showed a maximum release of 99.28% in 24 hrs and revealed that EC was more effective in sustaining the drug release therefore formulation F6 was selected as the optimized formulation. The in-vitro release data of optimized formulation was fit into various kinetic models, among the different model's data of in-vitro release of best fit into Zero order kinetic model. The formulation best fit the Higuchi model and showed that drug release from the prepared matrix tablets occurs via a diffusion process.

Publisher

EMU Journal of Pharmaceutical Sciences

Reference23 articles.

1. Adepu S, Ramakrishna S (2021). Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules (Basel, Switzerland) 26(19): 5905.

2. Adriana IS (2019). Preformulation: The use of FTIR in compatibility studies- review. Journal of Innovations in Applied Pharmaceutical Science 4(3): 01-06.

3. Ajit K, Trushali M, Nagesh A (2017). Application of novel natural polymer for controlling the release of fenoverine from controlled release matrix tablets. Int J Appl Pharm 9(2):1-9.

4. Ashok KN, Hadida H, Mohamed IN, Wan AWI (2001). Development of a High-Performance Liquid Chromatographic Method for Analysis of Glibenclamide from Dissolution Studies: Malaysian Journal of Pharmacy (MJP): 29-34.

5. Bhavani B, Kamala PV, Chowdary KPR (2012). Formulation and evaluation of glipizide sustained release tablets. International Journal of Pharmaceutical and biomedical Research 3(1): 44-48.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3